SynAct Pharma Announces Initiation of Coverage by BioVal BioStock Analytics

LUND, SE / ACCESS Newswire / November 3, 2026 / SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", …